Literature DB >> 5796352

Erythrocytosis associated with hemoglobin Rainier: oxygen equilibria and marrow regulation.

J W Adamson, J T Parer, G Stamatoyannopoulos.   

Abstract

Hemoglobin Rainier (beta(145) tyrosine-->histidine) is an abnormal hemoglobin associated with increased oxygen affinity, decreased heme-heme interaction, presence of a Bohr effect, and erythrocytosis, but without obvious clinical sequelae. Regulation of erythropoiesis was studied in affected members of families having either hemoglobin Rainier or Yakima, abnormal hemoglobins associated with erythrocytosis. Apart from the elevated but stable hemoglobin concentration and red cell mass, parameters of red cell production in the subjects were normal. Initially normal values of erythropoietin excretion were increased by phlebotomy indicating a significant hypoxic stress at an otherwise normal hematocrit. This stress led to increased reticulocyte production and an eventual return to the prephlebotomy hematocrit. The erythrocytosis in carriers of hemoglobins Rainer and Yakima appears to be secondary to the increased oxygen affinity and this, with the response to phlebotomy, is consistent with the postulate that the renal sensor tissue regulating erythropoietin production is primarily influenced by the oxygen tensions of venous rather than arterial blood.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5796352      PMCID: PMC322364          DOI: 10.1172/JCI106103

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  Nomograms and empirical equations relating oxygen tension, percentage saturation, and pH in maternal and fetal blood.

Authors:  A E HELLEGERS; J J SCHRUEFER
Journal:  Am J Obstet Gynecol       Date:  1961-02       Impact factor: 8.661

2.  Estimation of small percentages of foetal haemoglobin.

Authors:  K BETKE; H R MARTI; I SCHLICHT
Journal:  Nature       Date:  1959-12-12       Impact factor: 49.962

3.  A new technique for differentiation of hemoglobin.

Authors:  A R ROBINSON; M ROBSON; A P HARRISON; W W ZUELZER
Journal:  J Lab Clin Med       Date:  1957-11

4.  The use of chromium as red-cell tag.

Authors:  D M DONOHUE; A G MOTULSKY; E R GIBLETT; G PIRZIO-BIROLI; V VIRANUVATTI; C A FINCH
Journal:  Br J Haematol       Date:  1955-07       Impact factor: 6.998

5.  The erythropoietin-hematocrit relationship in normal and polycythemic man: implications of marrow regulation.

Authors:  J W Adamson
Journal:  Blood       Date:  1968-10       Impact factor: 22.113

6.  Hemoglobin Hiroshima (beta-143 histidine--aspartic acid): a newly identified fast moving beta chain variant associated with increased oxygen affinity and compensatory erythremia.

Authors:  H B Hamilton; I Iuchi; T Miyaji; S Shibata
Journal:  J Clin Invest       Date:  1969-03       Impact factor: 14.808

7.  Hemoglobin Yakina. I. Clinical and biochemical studies.

Authors:  R T Jones; E E Osgood; B Brimhall; R D Koler
Journal:  J Clin Invest       Date:  1967-11       Impact factor: 14.808

8.  Mixing technique for the oxygen-hemoglobin equilibrium and Bohr effect.

Authors:  M J Edwards; R J Martin
Journal:  J Appl Physiol       Date:  1966-11       Impact factor: 3.531

9.  Hemoglobin Yakina. II. High blood oxygen affinity associated with compensatory erythrocytosis and normal hemodynamics.

Authors:  M J Novy; M J Edwards; J Metcalfe
Journal:  J Clin Invest       Date:  1967-11       Impact factor: 14.808

10.  Urinary excretion of erythropoietin in normal men and women.

Authors:  R Alexanian
Journal:  Blood       Date:  1966-09       Impact factor: 22.113

View more
  12 in total

1.  Structure-function relations of human hemoglobins.

Authors:  Alain J Marengo-Rowe
Journal:  Proc (Bayl Univ Med Cent)       Date:  2006-07

2.  Human llamas: adaptation to altitude in subjects with high hemoglobin oxygen affinity.

Authors:  R P Hebbel; J W Eaton; R S Kronenberg; E D Zanjani; L G Moore; E M Berger
Journal:  J Clin Invest       Date:  1978-09       Impact factor: 14.808

3.  The physiological consequences of changes in oxygen affinity in the red cell enzyme defects.

Authors:  E R Huehns
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1974

Review 4.  Oxygen transport in chronic hypoxic lung disease.

Authors:  D C Flenley
Journal:  J Clin Pathol       Date:  1982-08       Impact factor: 3.411

5.  Hemoglobin Syracuse (alpha2beta2-143(H21)His leads to Pro), a new high-affinity variant detected by special electrophoretic methods. Observations on the auto-oxidation of normal and variant hemoglobins.

Authors:  M Jensen; F A Oski; D G Nathan; H F Bunn
Journal:  J Clin Invest       Date:  1975-03       Impact factor: 14.808

6.  Hemoglobin olympia ( 20 valine leads to methionine): an electrophoretically silent variant associated with high oxygen affinity and erythrocytosis.

Authors:  G Stamatoyannopoulos; P E Nute; J W Adamson; A J Bellingham; D Funk
Journal:  J Clin Invest       Date:  1973-02       Impact factor: 14.808

7.  Hemoglobinopathic erythrocytosis due to a new electrophoretically silent variant, hemoglobin San Diego (beta109 (G11)val--met).

Authors:  P E Nute; G Stamatoyannopoulos; M A Hermodson; D Roth
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

8.  Hemoglobin brigham (alpha2Abeta2100 Pro--Leu). Hemoglobin variant associated with familial erythrocytosis.

Authors:  J J Lokich; W C Moloney; H F Bunn; S M Bruckheimer; H M Ranney
Journal:  J Clin Invest       Date:  1973-08       Impact factor: 14.808

9.  Familial polycythaemia caused by a new haemoglobin variant: Hb Heathrow, beta 103 (G5) phenylalanine leads to leucine.

Authors:  J M White; L Szur; I D Gillies; P A Lorkin; H Lehmann
Journal:  Br Med J       Date:  1973-09-29

10.  Structural and functional studies on hemoglobin Bethesda (alpha2beta2 145His), a varient associated with compensatory erythrocytosis.

Authors:  H F Bunn; T B Bradley; W E Davis; J W Drysdale; J F Burke; W S Beck; M B Laver
Journal:  J Clin Invest       Date:  1972-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.